Trademark Overview
On Monday, December 4, 2023, a trademark application was filed for ECHO with the United States Patent and Trademark Office. The USPTO has given the ECHO trademark a serial number of 98298155. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, June 20, 2024. This trademark is owned by Ncardia B.V.. The ECHO trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacturing of cell culture and cell therapy systems, apparatus and equipment for others; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies, including using cell lines, iPS (induced pluripotent stem) cells, genetically modified iPS cells or differentiated cells derived therefrom, for others; custom manufacture of cellular therapies; information, advice and consultancy in relation to all the aforesaid.
Platform as a service (PaaS) featuring computer software platforms for developing cell therapies; providing temporary use of web-based software platforms for developing and characterizing cell lines; providing temporary use of non-downloadable computer software platforms for developing and manufacturing cell-based therapies and analyzing data for purposes of process optimization and quality control; laboratory research in the field of biotechnology in general and in particular using cell lines, iPS (induced pluripotent stem) cells, genetically modified iPS cells or differentiated cells derived therefrom; scientific research, design and technological development services in the field of biotechnology, for the pharmaceutical and medical industry; scientific research, design, testing and technological development of cell cultures, cell-based products, genetically modified cell products, cell therapies, and gene-edited cell therapy systems, equipment and apparatus; scientific research, des...
